Analystreport

CytomX Therapeutics Inc (NASDAQ: CTMX) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating.

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com